Optimal bevacizumab treatment strategy in advanced ovarian cancer: A review
Cancer Treatment Reviews · 2025-06 · 137 · 102945
DOI: 10.1016/j.ctrv.2025.102945 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2025-06. Verfasst von Bradley J Monk und 3 weiteren Autor:innen. Beteiligte Einrichtung: GOG Foundation, Philadelphia, PA, USA; Division of Gynecologic Oncology, Florida Cancer Specialists and Research Institute, West Palm Beach, FL, USA.…. Hauptthemen laut MEDLINE: Bevacizumab, Ovarian Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Agents, Immunological. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Merck Sharp & Dohme UK Ltd, AstraZeneca PLC.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- GOG Foundation, Philadelphia, PA, USA; Division of Gynecologic Oncology, Florida Cancer Specialists and Research Institute, West Palm Beach, FL, USA. Electronic address: bmonk@gog.org.
- Gynecologic Oncology Unit, Humanitas San Pio X, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
- Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
- Department of Gynecology with Center for Oncological Surgery, Charité-Universitätsmedizin Berlin, Berlin, and North-Eastern German Society of Gynecological Oncology (NOGGO) - Arbeitsgemeinschaft Gynäkologische Onkologie…
Förderung
- Merck Sharp & Dohme UK Ltd
- AstraZeneca PLC
Zitieren
APA
Monk, B. J., Lorusso, D., Fujiwara, K., & Sehouli, J. (2025). Optimal bevacizumab treatment strategy in advanced ovarian cancer: A review. Cancer Treatment Reviews, 137, 102945. https://doi.org/10.1016/j.ctrv.2025.102945
Vancouver
Monk BJ, Lorusso D, Fujiwara K, Sehouli J. Optimal bevacizumab treatment strategy in advanced ovarian cancer: A review. Cancer Treatment Reviews. 2025;137:102945. doi:10.1016/j.ctrv.2025.102945
BibTeX
@article{Monk2025,
author = {Monk, Bradley J and Lorusso, Domenica and Fujiwara, Keiichi and Sehouli, Jalid},
title = {Optimal bevacizumab treatment strategy in advanced ovarian cancer: A review},
journal = {Cancer Treatment Reviews},
year = {2025},
volume = {137},
pages = {102945},
doi = {10.1016/j.ctrv.2025.102945}
}
EUVIMED